Bryan E. Smith
Compliance Officer bij ELEDON PHARMACEUTICALS, INC.
Vermogen: - $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
James Robinson | M | 54 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 5 jaar |
Keith Katkin | M | 52 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 7 jaar |
Sef P. Kurstjens | M | 60 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 jaar |
David Hovland | M | - | 14 jaar | |
Myrtle Potter | F | 65 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 jaar |
Pierre Legault | M | 63 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 jaar |
Shigeyuki Nishinaka | M | 59 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 5 jaar |
James Hindman | M | 63 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 4 jaar |
Steven N. Perrin | M | 59 | 4 jaar | |
Jan Hillson | M | 71 | 3 jaar | |
June Lee | M | 58 | 4 jaar | |
David-Alexandre C. Gros | M | 51 | 4 jaar | |
Cornelia Haag-Molkenteller | M | 66 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 17 jaar |
Paul Little | M | 60 | 3 jaar | |
John S. McBride | M | 72 | 7 jaar | |
Allan Kirk | M | - | 1 jaar | |
Walter C. Ogier | M | 67 | 4 jaar | |
Yuichiro Haruyama | M | - |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 3 jaar |
Kenton Stewart | M | - | 4 jaar | |
John Herberger | M | - | 2 jaar | |
Alex Thurman | M | 54 | 8 jaar | |
Ajay Bansal | M | 62 | 5 jaar | |
Saee Muzumdar | F | - |
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | 16 jaar |
Walt Johnston | M | - | 4 jaar | |
Jim Hindman | M | - |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 4 jaar |
Brandon Williams | M | - |
Brigham Young University
| 22 jaar |
Lois F. Herzeca | F | - |
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | 15 jaar |
Eric T. McCrath | M | - |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | 17 jaar |
Eliezer Katz | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Scott Giacobello | M | 54 | 7 jaar | |
Paul Bisaro | M | 63 | 5 jaar | |
Jon S. Kuwahara | M | 59 | 4 jaar | |
Brenton Saunders | M | 56 | 6 jaar | |
David Adam Buchen | M | 59 | 1 jaar | |
Beau T. Seil | M | - |
Brigham Young University
| 6 jaar |
Jason Adam White | M | - |
Brigham Young University
| 5 jaar |
Aaron Powell | M | - |
Brigham Young University
| 6 jaar |
Gavin Gee | M | - |
Brigham Young University
| 7 jaar |
Andrew L. Turner | M | 77 | 2 jaar | |
Skyler Nelson | M | - |
Brigham Young University
| 5 jaar |
Peter John McDonnell | M | 66 | 5 jaar | |
Mark Oligschlaeger | M | - |
Brigham Young University
| 16 jaar |
Joel R. Hawkins | M | - |
Brigham Young University
| 5 jaar |
Christopher Coughlin | M | 71 | 6 jaar | |
Robbie G. Yates | M | - |
Brigham Young University
| 4 jaar |
Michael McFadden | M | 57 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 1 jaar |
Nicholas B. Wright | M | - |
Brigham Young University
| 4 jaar |
Jonathon Kellerman | M | - | 6 jaar | |
Rob McMillen | M | - |
Brigham Young University
| 4 jaar |
Benjamin Lambert | M | - |
Brigham Young University
| 10 jaar |
James Norman Ogilvie | M | 38 |
Brigham Young University
| 7 jaar |
Joseph H. Boccuzi | M | 77 | 3 jaar | |
Roger J. Lias | M | 63 | 6 jaar | |
Nori Ebersole | F | 60 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 23 jaar |
Dave Olsen | M | - |
Brigham Young University
| 6 jaar |
Jared Huish | M | - |
Brigham Young University
| 8 jaar |
Jennifer Ard | F | - |
Brigham Young University
| 7 jaar |
James McKean | M | - |
Brigham Young University
| 7 jaar |
Jonathan R. Erickson | M | 46 |
Brigham Young University
| 5 jaar |
Jeffrey T. Jensen | M | 44 |
Brigham Young University
| 7 jaar |
Ambrose Bailey | M | 60 | 6 jaar | |
Sigurdur Olafsson | M | 55 | 4 jaar | |
James H. Bloem | M | 73 | 5 jaar | |
John A. King | M | 74 | 2 jaar | |
Robert Todd Joyce | M | 66 | 1 jaar | |
Adriane Brown | M | 65 | 3 jaar | |
Patrick O’Sullivan | M | 82 | 5 jaar | |
Michael R. Gallagher | M | 77 | 2 jaar | |
George Frederick Wilkinson | M | 68 | 1 jaar | |
Gary Lyons | M | 73 | 6 jaar | |
Tamar Howson | F | 75 | 9 jaar | |
Hafrun Fridriksdottir | M | 62 | 14 jaar | |
Daniel G. Vetter | M | - |
Brigham Young University
| 5 jaar |
Jirí Michal | M | 71 | 2 jaar | |
Tom Pierce | M | - |
Brigham Young University
| 6 jaar |
C. Nicholson | M | 68 | 6 jaar | |
James Jackson | M | - |
Brigham Young University
| 6 jaar |
John Kelly | M | 57 | 6 jaar | |
Jon Petersen | M | - |
Brigham Young University
| 5 jaar |
Daphne Karydas | F | 49 | 3 jaar | |
Nesli Basgoz | M | 66 | 6 jaar | |
Daniel J. Hopkin | M | 46 |
Brigham Young University
| 5 jaar |
Cristian C. Turrini | M | 49 |
Brigham Young University
| 3 jaar |
Quan Mai | M | - |
Brigham Young University
| 4 jaar |
Jordan McDonnel | M | - |
Brigham Young University
| 4 jaar |
Matthew Dyer | M | - |
Brigham Young University
| 3 jaar |
Steve Christensen | M | - |
Brigham Young University
| 3 jaar |
David Nieman | M | - |
Brigham Young University
| 4 jaar |
Stephen Silvestro | M | 46 |
Brigham Young University
| 4 jaar |
Nathan Shields | M | - |
Brigham Young University
| 4 jaar |
Aaron Kimball Skidmore | M | - |
Brigham Young University
| 6 jaar |
Ryan Nielsen | M | - |
Brigham Young University
| 3 jaar |
Vonn Christenson | M | 44 |
Brigham Young University
| 4 jaar |
Zachary Mangum | M | - |
Brigham Young University
| 4 jaar |
Michael Wayne Pierson | M | - |
Brigham Young University
| 4 jaar |
Carly L. Mattson | F | - |
Brigham Young University
| 4 jaar |
Samuel Palmer | M | - |
Brigham Young University
| 7 jaar |
Brett Carlton D'Orlando | M | - |
Brigham Young University
| 4 jaar |
Dan Boston | M | - |
Brigham Young University
| 7 jaar |
James Sorenson | M | - |
Brigham Young University
| 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 68 | 68.00% |
Ierland | 30 | 30.00% |
Verenigd Koninkrijk | 12 | 12.00% |
Singapore | 2 | 2.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Bryan E. Smith
- Persoonlijk netwerk